272 related articles for article (PubMed ID: 32546231)
41. Fibroblast growth factor-21, body composition, and insulin resistance in pre-pubertal and early pubertal males and females.
Hanks LJ; Casazza K; Ashraf AP; Wallace S; Gutiérrez OM
Clin Endocrinol (Oxf); 2015 Apr; 82(4):550-6. PubMed ID: 25039824
[TBL] [Abstract][Full Text] [Related]
42. Asprosin serum levels and glucose homeostasis in children with obesity.
Corica D; Aversa T; Currò M; Tropeano A; Pepe G; Alibrandi A; Ientile R; Wasniewska M
Cytokine; 2021 Jun; 142():155477. PubMed ID: 33662891
[TBL] [Abstract][Full Text] [Related]
43. Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans.
Zhang X; Yeung DC; Karpisek M; Stejskal D; Zhou ZG; Liu F; Wong RL; Chow WS; Tso AW; Lam KS; Xu A
Diabetes; 2008 May; 57(5):1246-53. PubMed ID: 18252893
[TBL] [Abstract][Full Text] [Related]
44. Higher levels of serum α-Klotho are longitudinally associated with less central obesity in girls experiencing weight gain.
Carreras-Badosa G; Puerto-Carranza E; Mas-Parés B; Gómez-Vilarrubla A; Gómez-Herrera B; Díaz-Roldán F; Riera-Pérez E; de Zegher F; Ibañez L; Bassols J; López-Bermejo A
Front Endocrinol (Lausanne); 2023; 14():1218949. PubMed ID: 37522130
[TBL] [Abstract][Full Text] [Related]
45. The relationship between serum adiponectin, tumor necrosis factor-alpha, leptin levels and insulin sensitivity in childhood and adolescent obesity: adiponectin is a marker of metabolic syndrome.
Alikaşifoğlu A; Gönç N; Özön ZA; Sen Y; Kandemir N
J Clin Res Pediatr Endocrinol; 2009; 1(5):233-9. PubMed ID: 21274300
[TBL] [Abstract][Full Text] [Related]
46. Reduction in serum fibroblast growth factor-21 after gastric bypass is related to changes in hepatic fat content.
Fjeldborg K; Pedersen SB; Møller HJ; Richelsen B
Surg Obes Relat Dis; 2017 Sep; 13(9):1515-1523. PubMed ID: 28552744
[TBL] [Abstract][Full Text] [Related]
47. Fibroblast growth factor 21 (FGF21) in human cerebrospinal fluid: relationship with plasma FGF21 and body adiposity.
Tan BK; Hallschmid M; Adya R; Kern W; Lehnert H; Randeva HS
Diabetes; 2011 Nov; 60(11):2758-62. PubMed ID: 21926274
[TBL] [Abstract][Full Text] [Related]
48. Associations Between Serum Uric Acid Concentrations and Cardiometabolic Risk and Renal Injury in Obese and Overweight Children.
Özalp Kızılay D; Şen S; Ersoy B
J Clin Res Pediatr Endocrinol; 2019 Sep; 11(3):262-269. PubMed ID: 30759960
[TBL] [Abstract][Full Text] [Related]
49. Glucose tolerance status in 510 children and adolescents attending an obesity clinic in Central Italy.
Brufani C; Ciampalini P; Grossi A; Fiori R; Fintini D; Tozzi A; Cappa M; Barbetti F
Pediatr Diabetes; 2010 Feb; 11(1):47-54. PubMed ID: 19460122
[TBL] [Abstract][Full Text] [Related]
50. A study of insulin resistance by HOMA-IR and its cut-off value to identify metabolic syndrome in urban Indian adolescents.
Singh Y; Garg MK; Tandon N; Marwaha RK
J Clin Res Pediatr Endocrinol; 2013; 5(4):245-51. PubMed ID: 24379034
[TBL] [Abstract][Full Text] [Related]
51. Circulating FGF19 and FGF21 surge in early infancy from infra- to supra-adult concentrations.
Sánchez-Infantes D; Gallego-Escuredo JM; Díaz M; Aragonés G; Sebastiani G; López-Bermejo A; de Zegher F; Domingo P; Villarroya F; Ibáñez L
Int J Obes (Lond); 2015 May; 39(5):742-6. PubMed ID: 25599612
[TBL] [Abstract][Full Text] [Related]
52. Insulin resistance and impaired glucose tolerance in obese children and adolescents referred to a tertiary-care center in Israel.
Shalitin S; Abrahami M; Lilos P; Phillip M
Int J Obes (Lond); 2005 Jun; 29(6):571-8. PubMed ID: 15889115
[TBL] [Abstract][Full Text] [Related]
53. Metabolic alterations in adolescents with obstructive sleep apnea.
Bhushan B; Ayub B; Loghmanee DA; Billings KR
Int J Pediatr Otorhinolaryngol; 2015 Dec; 79(12):2368-73. PubMed ID: 26581829
[TBL] [Abstract][Full Text] [Related]
54. Metabolic Profiles in Obese Children and Adolescents with Insulin Resistance.
Kostovski M; Simeonovski V; Mironska K; Tasic V; Gucev Z
Open Access Maced J Med Sci; 2018 Mar; 6(3):511-518. PubMed ID: 29610610
[TBL] [Abstract][Full Text] [Related]
55. Prevalence of type 2 diabetes mellitus, metabolic syndrome, and related morbidities in overweight and obese children.
Dündar İ; Akıncı A
J Pediatr Endocrinol Metab; 2022 Apr; 35(4):435-441. PubMed ID: 35026882
[TBL] [Abstract][Full Text] [Related]
56. Cardiometabolic risk factors and insulin resistance in obese children and adolescents: relation to puberty.
Tobisch B; Blatniczky L; Barkai L
Pediatr Obes; 2015 Feb; 10(1):37-44. PubMed ID: 24227418
[TBL] [Abstract][Full Text] [Related]
57. Plasma concentrations of fibroblast growth factors 21 and 19 in patients with Cushing's syndrome.
Ďurovcová V; Marek J; Hána V; Matoulek M; Zikán V; Haluzíková D; Kaválková P; Lacinová Z; Krsek M; Haluzík M
Physiol Res; 2010; 59(3):415-422. PubMed ID: 19681655
[TBL] [Abstract][Full Text] [Related]
58. Daily physical activity, fasting glucose, uric acid, and body mass index are independent factors associated with serum fibroblast growth factor 21 levels.
Cuevas-Ramos D; Almeda-Valdes P; Gómez-Pérez FJ; Meza-Arana CE; Cruz-Bautista I; Arellano-Campos O; Navarrete-López M; Aguilar-Salinas CA
Eur J Endocrinol; 2010 Sep; 163(3):469-77. PubMed ID: 20566587
[TBL] [Abstract][Full Text] [Related]
59. Reduced levels of serum FGF19 and impaired expression of receptors for endocrine FGFs in adipose tissue from HIV-infected patients.
Gallego-Escuredo JM; Domingo P; Gutiérrez Mdel M; Mateo MG; Cabeza MC; Fontanet A; Vidal F; Domingo JC; Giralt M; Villarroya F
J Acquir Immune Defic Syndr; 2012 Dec; 61(5):527-34. PubMed ID: 23187887
[TBL] [Abstract][Full Text] [Related]
60. The value of different insulin resistance indices in assessment of non-alcoholic fatty liver disease in overweight/obese children.
El-Karaksy HM; El-Raziky MS; Fouad HM; Anwar GM; El-Mougy FM; El-Koofy NM; El-Hennawy AM
Diabetes Metab Syndr; 2015; 9(2):114-9. PubMed ID: 25470627
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
